ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods

被引:16
|
作者
Weintraub, Sandra [1 ,2 ]
Karpouzian-Rogers, Tatiana [1 ,2 ]
Peipert, John Devin [3 ]
Nowinski, Cindy [3 ,4 ]
Slotkin, Jerry [5 ]
Wortman, Katy [3 ]
Ho, Emily [3 ]
Rogalski, Emily [1 ,2 ]
Carlsson, Cynthia [6 ,7 ]
Giordani, Bruno [8 ]
Goldstein, Felicia [9 ]
Lucas, John [10 ]
Manly, Jennifer J. [11 ]
Rentz, Dorene [12 ,13 ]
Salmon, David [14 ]
Snitz, Beth [15 ]
Dodge, Hiroko H. [16 ]
Riley, Michaela [1 ]
Eldes, Fatima [1 ]
Ustsinovich, Vitali [3 ]
Gershon, Richard [3 ]
机构
[1] Northwestern Univ, Mesulam Ctr Cognit Neurol & Alzheimers Dis, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL USA
[3] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL USA
[4] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL USA
[5] Univ Delaware, Ctr Hlth Assessment Res & Translat, Delaware, OH USA
[6] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA
[7] Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA
[8] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
[9] Emory Univ, Dept Neurol, Atlanta, GA USA
[10] Mayo Clin, Dept Psychiat & Psychol, Jacksonville, FL USA
[11] Columbia Univ, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA
[12] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA
[13] Harvard Med Sch, Womens Hosp, Boston, MA USA
[14] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[15] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[16] Oregon Hlth & Sci Univ, Dept Neurol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognition; dementia; mild cognitive impairment; neuropsychology; NIH Toolbox; DATA SET UDS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; NIH TOOLBOX; RISK-FACTOR; IMPAIRMENT; DEMENTIA; RECOMMENDATIONS; DECLINE;
D O I
10.1002/alz.12497
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Early detection of cognitive decline in older adults is a public health priority. Advancing Reliable Measurement in Alzheimer's Disease and Cognitive Aging (ARMADA), a multisite study, is validating cognition, emotion, motor, and sensory modules of the National Institutes of Health Toolbox for Assessment of Neurological and Behavioral Function (NIHTB) in the aging spectrum from cognitively normal to dementia of the Alzheimer's type (DAT). Methods: Participants 65 to 85 years old, in demographic groups racially proportional to the general US population, are recruited in one of three groups to validate the NIHTB: cognitively normal, amnestic mild cognitive impairment (aMCI), or mild DAT. Additional special emphasis cohorts include (1) Blacks in the three clinical groups; (2) Spanish-speakers in the three clinical groups; (3) cognitively normal, population-proportional, over age 85. Discussion: Longitudinal study will determine whether NIHTB can predict cognitive decline and is associated with Alzheimer's disease biomarkers. Here, we detail the methods for the ARMADA study.
引用
收藏
页码:1449 / 1460
页数:12
相关论文
共 50 条
  • [31] Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study
    Scaricamazza, Eugenia
    Colonna, Isabella
    Sancesario, Giulia Maria
    Assogna, Francesca
    Orfei, Maria Donata
    Franchini, Flaminia
    Sancesario, Giuseppe
    Mercuri, Nicola Biagio
    Liguori, Claudio
    NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1377 - 1382
  • [32] Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
    Kirsebom, Bjorn-Eivind
    Espenes, Ragna
    Waterloo, Knut
    Hessen, Erik
    Johnsen, Stein Harald
    Brathen, Geir
    Aarsland, Dag
    Fladby, Tormod
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (04) : 1621 - 1631
  • [33] Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment
    Sandau, Ursula S.
    Wiedrick, Jack T.
    Smith, Sierra J.
    McFarland, Trevor J.
    Lusardi, Theresa A.
    Lind, Babett
    Harrington, Christina A.
    Lapidus, Jodi A.
    Galasko, Douglas R.
    Quinn, Joseph F.
    Saugstad, Julie A.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (01) : 245 - 263
  • [34] Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
    Maass, Anne
    Landau, Susan
    Baker, Suzanne L.
    Horng, Andy
    Lockhart, Samuel N.
    La Joie, Renaud
    Rabinovici, Gil D.
    Jagust, William J.
    NEUROIMAGE, 2017, 157 : 448 - 463
  • [35] Risk Classification in Mild Cognitive Impairment Patients for Developing Alzheimer's Disease
    Zhou, Bin
    Nakatani, Eiji
    Teramukai, Satoshi
    Nagai, Yoji
    Fukushima, Masanori
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (02) : 367 - 375
  • [36] A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments
    Garrett, Mario D.
    Valle, Ramon
    DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE, 2016, 15 (02): : 239 - 254
  • [37] Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia
    Pillai, Jagan A.
    Bermel, Robert
    Bonner-Jackson, Aaron
    Rae-Grant, Alexander
    Fernandez, Hubert
    Bena, James
    Jones, Stephen E.
    Ehlers, Justis P.
    Leverenz, James B.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 430 - 436
  • [38] Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease
    King, Eleanor
    O'Brien, John Tiernan
    Donaghy, Paul
    Morris, Christopher
    Barnett, Nicola
    Olsen, Kirsty
    Martin-Ruiz, Carmen
    Taylor, John Paul
    Thomas, Alan J.
    INTERNATIONAL PSYCHOGERIATRICS, 2019, 31 (04) : 551 - 560
  • [39] Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment
    Giacomucci, Giulia
    Mazzeo, Salvatore
    Bagnoli, Silvia
    Ingannato, Assunta
    Leccese, Deborah
    Berti, Valentina
    Padiglioni, Sonia
    Galdo, Giulia
    Ferrari, Camilla
    Sorbi, Sandro
    Bessi, Valentina
    Nacmias, Benedetta
    JOURNAL OF NEUROLOGY, 2022, 269 (08) : 4270 - 4280
  • [40] Mild Cognitive Impairment Progression and Alzheimer's Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months
    Oksuz, Nevra
    Ghouri, Reza
    Tasdelen, Bahar
    Uluduz, Derya
    Ozge, Aynur
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)